Alcoholic neuropathy: Possible mechanisms and future treatment possibilities

British Journal of Clinical Pharmacology

Volumn 73, Issue 3, 2012, Pages 348-362

  Chopra, Kanwaljit ^a   Tiwari, Vinod ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acetaldehyde; Alcoholic neuropathy; Benfotiamine; Caspase; Protein kinase C; Thiamine

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,6 DIAMINO N [[1 (1 OXOTRIDECYL) 2 PIPERIDYL]METHYL]HEXANAMIDE; ACETALDEHYDE; ACETYLCARNITINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; BENFOTIAMINE; CAPSAICIN; CYANOCOBALAMIN; DULOXETINE; FOLIC ACID; INOSITOL; MECOBALAMIN; METABOTROPIC RECEPTOR 5; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC ACID; OPIATE RECEPTOR; PROTEIN KINASE C EPSILON; PYRIDOXINE; RIBOFLAVIN; THIAMINE; THIOCTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VITAMIN B COMPLEX;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; DIABETIC NEUROPATHY; DISEASE DURATION; DISEASE SEVERITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MICROGLIA; NERVE DEGENERATION; NERVE FIBER; NEUROPATHY; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; SPINAL CORD; THIAMINE DEFICIENCY;

ALCOHOL DRINKING; ALCOHOLIC NEUROPATHY; ALCOHOLISM; ETHANOL; HUMANS; HYPERALGESIA; PAIN; PAIN THRESHOLD; PERIPHERAL NERVES; THIAMINE DEFICIENCY; TIME FACTORS;

EID: 84857007815     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04111.x     Document Type: Article

References (132)

1. Ratcliff EV. Alcoholic neuropathies. Aust Fam Physician 1979; 8: 171-7.
2. Koike H, Mori K, Misu K, Hattori N, Ito H, Hirayama M, Sobue G. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001a; 56: 1727-32.
3. Koike H, Iijima M, Sugiura M, Mori K, Hattori N, Ito H, Hirayama M, Sobue G. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003; 54: 19-29.
4. Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol 2006; 19: 481-6.
5. Bosch EP, Pelham RW, Rasool CG, Chatterjee A, Lash RW, Brown L, Munsat TL, Bradley WG. Animal models of alcoholic neuropathy: morphologic, electrophysiologic, and biochemical findings. Muscle Nerve 1979; 2: 134-44.
6. Monforte R, Estruch R, Valls-Solé J, Nicolás J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol. Arch Neurol 1995; 52: 45-51.
7. Palliyath S, Schwartz BD. Peripheral nerve functions improve in chronic alcoholic patients on abstinence. J Stud Alcohol 1993; 54: 684-6.
8. Brain L, Walton JN. Disorders of peripheral nerves: alcoholic polyneuritis. In: Brain's Diseases of the Nervous System. London: Oxford University Press, 1969; 817-19.
9. Ammendola A, Gemini D, Iannaccone S, Argenzio F, Ciccone G, Ammendola E, Serio L, Ugolini G, Bravaccio F. Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol Alcohol 2000; 35: 368-71.
10. Dina OA, Gear RW, Messing RO, Levine JD. Severity of alcohol-induced painful peripheral neuropathy in female rats: role of estrogen and protein kinase (A and C epsilon). Neuroscience 2007; 145: 350-6.
11. Hawley RJ, Kurtzke JF, Armbrustmacher VW, Saini N, Manz H. The course of alcoholic-nutritional peripheral neuropathy. Acta Neurol Scand 1982; 66: 582-89.
12. Singleton CK, Martin PR. Molecular mechanisms of thiamine utilization. Curr Mol Med 2001; 1: 197-07.
13. Ammendola A, Tata MR, Aurilio C, Ciccone G, Gemini D, Ammendola E, Ugolini G, Argenzio F. Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcohol Alcohol 2001; 36: 271-75.
14. Narita M, Miyoshi K, Narita M, Suzuki T. Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett 2007; 414: 21-5.
15. Miyoshi K, Narita M, Takatsu M, Suzuki T. mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. Eur J Pharmacol 2007; 562: 208-11.
16. Dina OA, Barletta J, Chen X, Mutero A, Martin A, Messing RO, Levine JD. Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 2000; 20: 8614-9.
17. Gianoulakis C, Dai X, Brown T. Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender. Alcohol Clin Exp Res 2003; 27: 410-23.
18. Thayer JF, Hall M, Sollers JJ 3rd, Fischer JE. Alcohol use, urinary cortisol, and heart rate variability in apparently healthy men: evidence for impaired inhibitory control of the HPA axis in heavy drinkers. Int J Psychophysiol 2006; 59: 244-50.
19. Walter M, Gerhard U, Gerlach M, Weijers HG, Boening J, Wiesbeck GA. Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence. Addict Biol 2006; 11: 157-62.
20. Ludin HP, Tackman W. Polyneuropathien. Stuttgart, New York: Georg Thieme Verlag, 1984; 250-55.
21. Kucera P, Balaz M, Varsik P, Kurca E. Pathogenesis of alcoholic neuropathy. Bratisl Lek Listy 2002; 103: 26-9.
22. Achord JL. Alcohol and the liver. Sci Amer Sci Med 1995; 2: 16-25.
23. Scheid W. Lehrbuch der Neurologie. Vierte Auflage. Stuttgart: Georg Thieme Verlag, 1980.
24. Victor M, Adams RD. On the etiology of the alcoholic neurologic diseases with special reference to the role of nutrition. Am J Clin Nutr 1961; 9: 379-97.
25. Novak DJ, Victor M. The vagus and sympathetic nerves in alcoholic polyneuropathy. Arch Neurol 1974; 30: 273-84.
26. Koike H, Iijima M, Mori K, Hattori N, Ito H, Hirayama M, Sobue G. Postgastrectomy polyneuropathy with thiamine deficiency is identical to beriberi neuropathy. Nutrition 2004; 20: 961-6.
27. Koike H, Misu K, Hattori N, Ito S, Ichimura M, Ito H, Hirayama M, Nagamatsu M, Sasaki I, Sobue G. Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry 2001b; 71: 357-62.
28. Koike H, Ito S, Morozumi S, Kawagashira Y, Iijima M, Hattori N, Tanaka F, Sobue G. Rapidly developing weakness mimicking Guillain-Barré syndrome in beriberi neuropathy: two case reports. Nutrition 2008; 24: 776-80.
29. Ohnishi A, Tsuji S, Igisu H, Murai Y, Goto I, Kuroiwa Y, Tsujihata M, Takamori M. Beriberi neuropathy: morphometric study of sural nerve. J Neurol Sci 1980; 45: 177-90.
30. Tackmann W, Minkenberg R, Strenge H. Correlation of electrophysiological and quantitative histological findings in the sural nerve of man. Studies on alcoholic neuropathy. J Neurol 1977; 216: 289-99.
31. Behse F, Buchthal F. Alcohol neuropathy: clinical, electrophysiological and biopsy findings. Ann Neurol 1977; 2: 95-110.
32. Zambelis T, Karandreas N, Tzavellas E, Kokotis P, Liappas J. Large and small fiber neuropathy in chronic alcohol-dependent subjects. J Peripher Nerv Syst 2005; 10: 375-81.
33. Masaki T, Mochizuki H, Matsushita S, Yokoyama A, Kamakura K, Higuchi S. Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans. Neurosci Lett 2004; 363: 288-90.
34. Lieber CS. Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. J Stud Alcohol 1998; 59: 9-25.
35. Takeuchi M, Saito T. Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration. Alcohol Clin Exp Res 2005; 29: (Suppl.): 220S-4S.
36. Lee I, Kim HK, Kim JH, Chung K, Chung JM. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007; 133: 9-17.
37. Padi SS, Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol 2008; 601: 79-87.
38. Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR, Kumar D. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain 2006; 10: 573-9.
39. Kim HK, Park SK, Zhou JL, Taglialatela G, Chung K, Coggeshall RE, Chung JM. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004; 111: 116-24.
40. Sharma SS, Sayyed SG. Effects of Trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Clin Exp Pharmacol Physiol 2006; 33: 1022-102.
41. Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 2001; 11: 336-42.
42. Raghavendra V, Tanga FY, DeLeo JA. Inhibition of microglia activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003; 306: 624-30.
43. Cooper AJ, Kristal BS. Multiple roles of glutathione in the central nervous system. Biol Chem 1997; 378: 793-802.
44. Wullner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Löschmann P, Schulz JB, Weller M, Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 1999; 826: 53-62.
45. Levy D, Zochodne DW. NO pain: potential roles of nitric oxide in neuropathic pain. Pain Pract 2004; 4: 11-8.
46. Sung CS, Wen ZH, Chang WK, Ho ST, Tsai SK, Chang YC, Wong CS. Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res 2004; 1015: 145-53.
47. Lin Q, Wu J, Peng YB, Cui M, Willis WD. Nitric oxide-mediated spinal disinhibition contributes to the sensitization of primate spinothalamic tract neurons. J Neurophysiol 1999; 81: 1086-94.
48. Mantle D, Preedy VR. Free radicals as mediators of alcohol toxicity. Adverse Drug React Toxicol Rev 1999; 18: 235-52.
49. Zima T, Fialova L, Mestek O, Janebova M, Crkovska J, Malbohan I, Stipek S, Mikulikova L, Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci 2001; 8: 59-70.
50. Dicker E, Cederbaum AI. Increased NADH-dependent production of reactive oxygen intermediates by microsomes after chronic ethanol consumption: comparisons with NADPH. Arch Biochem Biophys 1992; 293: 274-80.
51. Mansouri A, Demeilliers C, Amsellem S, Pessayre D, Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther 2001; 298: 737-43.
52. McDonough KH. Antioxidant nutrients and alcohol. Toxicology 2003; 189: 89-97.
53. Bosch-Morell F, Martinez-Soriano F, Colell A, Fernandez-Checa JC, Romero FJ. Chronic ethanol feeding induces cellular antioxidants decrease and oxidative stress in rat peripheral nerves: effect of s-adenosyl-l-methionine and n-acetyl-l-cysteine. Free Radic Biol Med 1998; 25: 365-68.
54. Tiwari V, Kuhad A, Chopra K. Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy. Eur J Pain 2011; 15: 286-92.
55. Tiwari V, Kuhad A, Chopra K. Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain 2009; 145: 129-35.
56. Aley KO, Levine JD. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 2002; 111: 389-97.
57. Ahlgren SC, Levine JD. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 1994; 72: 684-92.
58. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 1989; 32: 577-80.
59. Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO. A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 1999; 24: 253-60.
60. Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 2001; 21: 6933-39.
61. Dina OA, McCarter GC, de Coupade C, Levine JD. Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron 2003; 39: 613-24.
62. Dina OA, Hucho T, Yeh J, Malik-Hall M, Reichling DB, Levine JD. Primary afferent second messenger cascades interact with specific integrin subunits in producing inflammatory hyperalgesia. Pain 2005; 115: 191-203.
63. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114: 149-59.
64. Dina OA, Aley KO, Isenberg W, Messing RO, Levine JD. Sex hormones regulate the contribution of PKCepsilon and PKA signalling in inflammatory pain in the rat. Eur J Neurosci 2001; 13: 2227-33.
65. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005; 115: 71-83.
66. Watkins LR, Milligan ED, Maier SF. Spinal cord glia: new players in pain. Pain 2001; 93: 201-5.
67. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413: 203-10.
68. Norenberg ND. Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 1994; 53: 213-20.
69. Robbins MA, Maksumova L, Pocock E, Chantler JK. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL). Endocrinology 2003; 144: 4616-25.
70. Krebs JF, Armstrong RC, Srinivasan A, Aja T, Wong AM, Aboy A, Sayers R, Pham B, Vu T, Hoang K, Karanewsky DS, Leist C, Schmitz A, Wu JC, Tomaselli KJ, Fritz LC. Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J Cell Biol 1999; 144: 915-26.
71. Joseph EK, Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 2004; 20: 2896-902.
72. Jung ME, Gatch MB, Simpkins JW. Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms. Exp Biol Med (Maywood) 2005; 230: 8-22.
73. Izumi Y, Kitabayashi R, Funatsu M, Izumi M, Yuede C, Hartman RE, Wozniak DF, Zorumski CF. A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, N-methyl-D-aspartate receptor function and ethanol sensitivity. Neuroscience 2005; 136: 269-79.
74. Meller ST, Dykstra C, Gebhart GF. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl d-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience 1996; 71: 327-35.
75. Young MR, Fleetwood-Walker SM, Dickinson T, Blackburn-Munro G, Sparrow H, Birch PJ, Bountra C. Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res 1997; 777: 161-9.
76. Jia H, Rustioni A, Valtschanoff JG. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 1999; 410: 627-42.
77. Valerio A, Paterlini M, Boifava M, Memo M, Spano P. Metabotropic glutamate receptor mRNA expression in rat spinal cord. Neuroreport 1997; 8: 2695-9.
78. Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, Winter J. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 2002; 22: 2660-8.
79. al-Ghoul WM, Volsi GL, Weinberg RJ, Rustioni A. Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res Bull 1993; 30: 453-59.
80. Miyoshi K, Narita M, Narita M, Suzuki T. Involvement of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett 2006; 410: 105-9.
81. Tracey DJ, Cunningham JE, Romm MA. Peripheral hyperalgesia in experimental neuropathy: mediation by alpha 2-adrenoreceptors on postganglionic sympathetic terminals. Pain 1995; 60: 317-27.
82. Singh B, Moodley J, Shaik AS, Robbs JV. Sympathectomy for complex regional pain syndrome. J Vasc Surg 2003; 37: 508-11.
83. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004; 24: 8595-605.
84. Dina OA, Khasar SG, Alessandri-Haber N, Green PG, Messing RO, Levine JD. Alcohol-induced stress in painful alcoholic neuropathy. Eur J Neurosci 2008; 27: 83-92.
85. Quintero L, Cuesta MC, Silva JA, Arcaya JL, Pinerua-Suhaibar L, Maixner W, Suarez-Roca H. Repeated swim stress increases pain induced expression of c-Fos in the rat lumbar cord. Brain Res 2003; 965: 259-68.
86. Khasar SG, Green PG, Levine JD. Repeated sound stress enhances inflammatory pain in the rat. Pain 2005; 116: 79-86.
87. Yerdelen D, Koc F, Uysal H. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy. Neurol Res 2008; 30: 746-50.
88. McLane JA. Decreased axonal transport in rat nerve following acute and chronic ethanol exposure. Alcohol 1987; 4: 385-89.
89. Hellweg R, Baethge C, Hartung HD, Brückner MK, Arendt T. NGF level in the rat sciatic nerve is decreased after long-term consumption of ethanol. Neuroreport 1996; 7: 777-80.
90. Malatova Z, Cizkova D. Effect of ethanol on axonal transport of cholinergic enzymes in rat sciatic nerve. Alcohol 2002; 26: 115-20.
91. Saunders DE, DiCerbo JA, Williams JR, Hannigan JH. Alcohol reduces neurofilament protein levels in primary cultured hippocampal neurons. Alcohol 1997; 14: 519-26.
92. Guru SC, Shetty KT, Shankar SK. Effect of chronic ethanol ingestion on phosphate content of neurofilament proteins and neurofilament associated protein phosphatase in rat spinal cord. Neurochem Res 1991; 16: 1193-97.
93. Ahluwalia B, Ahmad S, Adeyiga O, Wesley B, Rajguru S. Low levels of ethanol stimulate and high levels decrease phosphorylation in microtubule-associated proteins in rat brain: an in vitro study. Alcohol Alcohol 2000; 35: 452-57.
94. Kannarkat GT, Tuma DJ, Tuma PL. Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells. J Hepatol 2006; 44: 963-70.
95. Depaz IM, de Las Heras R, Kroon PA, Wilce PA. Changes in neuronal protein 22 expression and cytoskeletal association in the alcohol-dependent and withdrawn rat brain. J Neurosci Res 2005; 81: 253-60.
96. Netzel M, Ziems M, Jung KH, Noll E, Borsch C, Bitsch I. Effect of high-dosed thiamine hydrochloride and S-benzoylthiamine- O-monophosphate on thiamine-status after chronic ethanol administration. Biofactors 2000; 11: 111-3.
97. Woelk H, Lehrl S, Bitsch R, Kopcke W. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study). Alcohol Alcohol 1998; 33: 631-38.
98. Anisimova EI, Danilov AB. Benfotiamine efficacy in alcoholic polyneuropathy therapy. Zh Nevrol Psikhiatr Im S S Korsakova 2001; 101: 32-6.
99. Kishi Y, Schmelzer JD, Yao JK, Zollman PJ, Nickander KK, Tritschler HJ, Low PA. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 1999; 48: 2045-51.
100. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 2000; 49: 1006-15.
101. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18: 1160-67.
102. Maestri A, De Pasquale Ceratti A, Cundari S, Zanna C, Cortesi E, Crinò L. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori 2005; 91: 135-38.
103. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res 2003; 9: 5756-67.
104. Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998; 21: 1915-18.
105. Nickander KK, Schmelzer JD, Rohwer DA, Low PA. Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci 1994; 126: 6-14.
106. Saperstein DS, Barohn RJ. Peripheral neuropathy due to cobalamin deficiency. Curr Treat Options Neurol 2002; 4: 197-01.
107. Weir DG, Scott JM. The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol 1995; 8: 479-97.
108. Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 2005; 14: 48-54.
109. Sundkvist G, Dahlin LB, Nilsson H, Eriksson KF, Lindgärde F, Rosén I, Lattimer SA, Sima AA, Sullivan K, Greene DA. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med 2000; 17: 259-68.
110. Carrington AL, Calcutt NA, Ettlinger CB, Gustafsson T, Tomlinson DR. Effects of treatment with myo-inositol or its 1, 2, 6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol 1993; 237: 257-63.
111. Love A, Cotter MA, Cameron NE. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats. Eur J Clin Invest 1996; 26: 698-706.
112. Park SA, Choi KS, Bang JH, Huh K, Kim SU. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 2000; 75: 946-53.
113. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 1995; 7: 317-28.
114. No authors listed. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch Intern Med 1991; 151: 2225-9.
115. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305.
116. Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 2007; 88: 1547-60.
117. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004; 110: 697-06.
118. Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6: 346-56.
119. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992; 52: 547-52.
120. Sandercock D, Cramer M, Wu J, Chiang YK, Biton V, Heritier M. Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Care 2009; 32: e20.
121. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001; 56: 184-90.
122. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001; 57: 505-09.
123. Silver M, Blum D, Grainger J, Hammer AE, Quessy S. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage 2007; 34: 446-54.
124. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008; 112: 2802-8.
125. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002; 106: 248-52.
126. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, Garg P. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004; 97: 33-8.
127. Kochar DK, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, Rawat N. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM 2005; 98: 29-34.
128. Otto M, Bach FW, Jensen TS, Sindrup SH. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 2004; 62: 285-8.
129. Drewes AM, Andreasen A, Poulsen LH. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia 1994; 32: 565-69.
130. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain 2007; 23: 150-8.
131. Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009; 25: 376-85.
132. Ziegler D, Hidvégi T, Gurieva I, Bongardt S, Freynhagen R, Sen D, Sommerville K, Lacosamide SP743 Study Group. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010; 33: 839-41.